The Evolving HER2+ Metastatic Breast Cancer Treatment Landscape

A panel of experts review data from recent conferences and discuss core challenges in the treatment of patients with HER2+ metastatic breast cancer.

EP. 1: Treatment Landscape for HER2+ Metastatic Breast Cancer

November 16th 2021

Panelists provide an overview of the treatment landscape for patients with HER2-positive metastatic breast cancer.

EP. 2: Treating Recurrent HER2+ Metastatic Breast Cancer Given Recent Clinical Trials

November 16th 2021

A panel of experts reviews clinical trial data in recurrent HER2-positive metastatic breast cancer and discusses impacts on treatment selection.

EP. 3: Considerations for HER2+ mBC Management: Biomarkers and Bone Disease

November 23rd 2021

Fielding questions from a live audience, experts discuss the lack of biomarkers in HER2+ metastatic breast cancer and how one might address progression of bone disease.

EP. 4: Patient Case #1: Frontline Therapy for HER2+ mBC

November 23rd 2021

Using a patient case to center their discussion, the panel reviews frontline treatment options for HER2+ metastatic breast cancer and the rationale behind selection.